438 related articles for article (PubMed ID: 17181645)
1. Telomeres rather than telomerase a key target for anti-cancer therapy?
Boukamp P; Mirancea N
Exp Dermatol; 2007 Jan; 16(1):71-9. PubMed ID: 17181645
[TBL] [Abstract][Full Text] [Related]
2. Pharmacological intervention strategies for affecting telomerase activity: future prospects to treat cancer and degenerative disease.
Tárkányi I; Aradi J
Biochimie; 2008 Jan; 90(1):156-72. PubMed ID: 17945408
[TBL] [Abstract][Full Text] [Related]
3. New ways not to make ends meet: telomerase, DNA damage proteins and heterochromatin.
Chan SW; Blackburn EH
Oncogene; 2002 Jan; 21(4):553-63. PubMed ID: 11850780
[TBL] [Abstract][Full Text] [Related]
4. Possible mechanisms for the regulation of telomere length.
Kowald A
J Mol Biol; 1997 Nov; 273(4):814-25. PubMed ID: 9367774
[TBL] [Abstract][Full Text] [Related]
5. Telomeres, telomerase and cancer: is the magic bullet real?
Sharma HW; Maltese JY; Zhu X; Kaiser HE; Narayanan R
Anticancer Res; 1996; 16(1):511-5. PubMed ID: 8615664
[TBL] [Abstract][Full Text] [Related]
6. Ageing and cancer: the telomere and telomerase connection.
Shay JW; Wright WE
Novartis Found Symp; 2001; 235():116-25; discussion 125-9, 146-9. PubMed ID: 11280022
[TBL] [Abstract][Full Text] [Related]
7. Overcoming the immortality of tumour cells by telomere and telomerase based cancer therapeutics--current status and future prospects.
Kelland LR
Eur J Cancer; 2005 May; 41(7):971-9. PubMed ID: 15862745
[TBL] [Abstract][Full Text] [Related]
8. Telomeres, telomerase and chromosome stability.
Preston RJ
Radiat Res; 1997 May; 147(5):529-34. PubMed ID: 9146697
[TBL] [Abstract][Full Text] [Related]
9. [Telomeres, telomerase and development of cancer].
Andersen TI
Tidsskr Nor Laegeforen; 1998 May; 118(13):2043-6. PubMed ID: 9656791
[TBL] [Abstract][Full Text] [Related]
10. Protection against chromosome degradation at the telomeres.
Grandin N; Charbonneau M
Biochimie; 2008 Jan; 90(1):41-59. PubMed ID: 17764802
[TBL] [Abstract][Full Text] [Related]
11. [Inhibition of telomeres and telomerase. Seeking for new anticancer drugs].
Raymond E; Faivre S; Dieras V; Von Hoff D
Bull Cancer; 1997 Dec; 84(12):1123-33. PubMed ID: 9587365
[TBL] [Abstract][Full Text] [Related]
12. [Telomere and telomerase in human cancer].
Hiyama K; Hiyama E; Ishioka S; Yamakido M
Gan To Kagaku Ryoho; 1997 Jan; 24(2):196-201. PubMed ID: 9030230
[TBL] [Abstract][Full Text] [Related]
13. The telomere and telomerase: nucleic acid-protein complexes acting in a telomere homeostasis system. A review.
Blackburn EH
Biochemistry (Mosc); 1997 Nov; 62(11):1196-201. PubMed ID: 9467842
[TBL] [Abstract][Full Text] [Related]
14. Telomere maintenance in clinical medicine.
Ulaner GA
Am J Med; 2004 Aug; 117(4):262-9. PubMed ID: 15308436
[TBL] [Abstract][Full Text] [Related]
15. Telomere-based cancer treatment: emerging targeted therapies.
Chen M; McLeskey SW
Clin J Oncol Nurs; 2010 Dec; 14(6):720-6. PubMed ID: 21112850
[TBL] [Abstract][Full Text] [Related]
16. Telomeres: hallmarks of radiosensitivity.
Ayouaz A; Raynaud C; Heride C; Revaud D; Sabatier L
Biochimie; 2008 Jan; 90(1):60-72. PubMed ID: 18006207
[TBL] [Abstract][Full Text] [Related]
17. Telomerase as a clinical target: current strategies and potential applications.
Fleisig HB; Wong JM
Exp Gerontol; 2007; 42(1-2):102-12. PubMed ID: 16814507
[TBL] [Abstract][Full Text] [Related]
18. Tankyrase 1 as a target for telomere-directed molecular cancer therapeutics.
Seimiya H; Muramatsu Y; Ohishi T; Tsuruo T
Cancer Cell; 2005 Jan; 7(1):25-37. PubMed ID: 15652747
[TBL] [Abstract][Full Text] [Related]
19. Telomere dynamics and telomerase activation in tumor progression: prospects for prognosis and therapy.
Healy KC
Oncol Res; 1995; 7(3-4):121-30. PubMed ID: 8555645
[TBL] [Abstract][Full Text] [Related]
20. A human cell line that maintains telomeres in the absence of telomerase and of key markers of ALT.
Cerone MA; Autexier C; Londoño-Vallejo JA; Bacchetti S
Oncogene; 2005 Nov; 24(53):7893-901. PubMed ID: 16116482
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
